Evidence for the in vivo expression of a distant downstream gene under the control of ColE1 replication origin

Applied Microbiology and Biotechnology
Sofia C RibeiroGabriel A Monteiro

Abstract

ColE1-like plasmids are widely used as expression vectors and as gene delivery vehicles. We have recently described a naturally occurring plasmid deletion phenomenon in the ColE1-type plasmid, pCI-neo, which leads to the detectable expression of an apparently promotorless kanamycin resistance gene. In the current work, we found that the expression of that aminoglycoside phosphotransferase (aph) gene is regulated by an RNAII preprimer promoter located within the plasmid ColE1 replication origin, as a consequence of the extension of the RNA II species for at least 1.5 kb, up to the aph gene. This mechanism is dependent on the nonformation and/or dissociation of the hybrid between plasmid DNA and RNA II preprimer transcript. This is the first in vivo description of RNA II transcription beyond ori in wild-type Escherichia coli strains and nonmutated RNAII plasmid sequences resulting in productive transcription of distant downstream genes. Our results raise questions about unwanted expression of genes from expression or cloning vectors of ColE1 type and highlight the importance of a more careful design of ColE1-derived plasmid vectors.

References

Feb 1, 1991·Journal of Bacteriology·N Inoue, H Uchida
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·T Itoh, J Tomizawa
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·J TomizawaT Som
Nov 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·S Naito, H Uchida
Feb 12, 1998·Proceedings of the National Academy of Sciences of the United States of America·S M Uptain, M J Chamberlin
Jun 10, 1998·Microbiology and Molecular Biology Reviews : MMBR·G del SolarR Díaz-Orejas
Jan 5, 1999·Frontiers in Bioscience : a Journal and Virtual Library·L A ActisJ H Crosa
May 15, 2002·Trends in Biotechnology·Reingard Grabherr, Karl Bayer
Apr 28, 2004·Plasmid·Zhijun WangUlrich R Hengge
Oct 20, 2004·Molecular Microbiology·J Gowrishankar, R Harinarayanan
Feb 12, 2008·Journal of Applied Genetics·Grzegorz Wegrzyn, Alicja Wegrzyn
May 6, 2008·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Maria AmbraziMichael Kokkinidis
Jul 9, 2008·Molecular Biotechnology·Sofia C RibeiroGabriel A Monteiro
Feb 24, 2009·Biotechnology Advances·James A WilliamsClague P Hodgson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.